newsfilter
← Earnings
Earnings Releases·

Iridex Corporation — Third Quarter 2026 Earnings Summary

Iridex Corporation reported third-quarter 2026 total revenue of $10.2 million, a 19% decline from the prior year period, driven by weaker demand in Europe and Asia and distributor inventory adjustments. The company achieved a gross margin of 42.4%, an improvement over the previous year, while operating expenses remained flat at $5.5 million. Net loss for the quarter was $1.4 million, or $0.08 per share, compared to a $1.6 million loss in the same period last year. Consequently, Iridex reduced its full-year 2026 revenue guidance to a range of $46 million to $48 million, citing continued headwinds in international markets.

Company
IRIDEX CORP
Sector
Healthcare
Industry
Medical Devices